GreenLight Biosciences Holdings
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRNA research report →
About the company
GreenLight Biosciences Holdings is a biotechnology firm focused on developing and commercializing ribonucleic acid (RNA) solutions. Its innovative products serve both the human health and agricultural industries. The company's human health portfolio includes mRNA vaccines and various therapeutic treatments, while its agricultural offerings feature RNA-based innovations designed to protect honeybees and defend crops.
- CEO
- Andrey Juan Zarur
- IPO
- 2022
- Employees
- 280
- HQ
- Medford, MA, US
Price Chart
- Market Cap
- $45.43M
- P/E
- -0.24
- P/S
- 7.12
- P/B
- 0.82
- EV/EBITDA
- -0.38
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -2567.65%
- Net Margin
- -2616.78%
- ROE
- -1847.24%
- ROIC
- -126.46%
- Revenue
- $6.38M · 0.00%
- Net Income
- $-167,055,000 · -45.61%
- EPS
- $-1.27 · -36.56%
- Op Income
- $-163,919,000
- FCF YoY
- -52.62%
- 52W High
- $5.90
- 52W Low
- $0.18
- 50D MA
- $0.27
- 200D MA
- $0.85
- Beta
- 1.44
- Avg Volume
- 684.80K
Get TickerSpark's AI analysis on GRNA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 24, 23 | KODIAK VENTURE PARTNERS III LP | other | 9,809,895 |
| May 29, 23 | KODIAK VENTURE PARTNERS III LP | other | 0 |
| Jul 24, 23 | Clarke Dennis A. | other | 25,510.204 |
| Jul 24, 23 | Anderson Eric Senior | other | 25,510.204 |
| Jul 24, 23 | Cummings Foundation, Inc. | other | 1,275,510.204 |
| Jul 24, 23 | COONEY CHARLES L | other | 305,314 |
| Jul 24, 23 | Insud Pharma S.L. | other | 2,551,020 |
| May 29, 23 | MLS Capital Fund II LP | other | 0 |
| Jul 24, 23 | MLS Capital Fund II LP | other | 5,818,575 |
| Jul 24, 23 | PATRICK DEVAL L | other | 172,500 |
Our GRNA coverage
Recent articles, reports, and earnings notes.
No research on GRNA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GRNA report →Similar companies
Peers in the same neighborhood.